Dexilant and Heavy or prolong menstrual bleeding - a phase IV clinical study of FDA data
Heavy or prolong menstrual bleeding is found among people who take Dexilant, especially for people who are 30-39 old.
The phase IV clinical study analyzes which people take Dexilant and have Heavy or prolong menstrual bleeding. It is created by eHealthMe based on reports of 51,355 people who have side effects when taking Dexilant from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
51,355 people reported to have side effects when taking Dexilant.
Among them, 52 people (0.1%) have Heavy or prolong menstrual bleeding.
What is Dexilant?
Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 52,238 Dexilant users for its effectiveness, alternative drugs and more.
What is Heavy or prolong menstrual bleeding?
Heavy or prolong menstrual bleeding is found to be associated with 1,678 drugs and 1,147 conditions by eHealthMe.
Number of Dexilant and Heavy or prolong menstrual bleeding reports submitted per year:
Age of people who have Heavy or prolong menstrual bleeding when taking Dexilant *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 3.7 %
- 30-39: 62.96 %
- 40-49: 7.41 %
- 50-59: 25.93 %
- 60+: 0.0 %
Common drugs people take besides Dexilant *:
- Breo Ellipta: 18 people, 34.62%
- Arava: 13 people, 25.00%
- Celebrex: 12 people, 23.08%
- Estrogel: 12 people, 23.08%
- Ventolin Hfa: 12 people, 23.08%
- Plaquenil: 10 people, 19.23%
- Nasonex: 9 people, 17.31%
- Claritin: 9 people, 17.31%
- Symbicort: 9 people, 17.31%
- Singulair: 9 people, 17.31%
Common side effects people have besides Heavy or prolong menstrual bleeding *:
- Nausea (feeling of having an urge to vomit): 31 people, 59.62%
- Cough: 24 people, 46.15%
- Joint Pain: 23 people, 44.23%
- Muscle Aches (muscle pain): 21 people, 40.38%
- Weight Decreased: 19 people, 36.54%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 18 people, 34.62%
- Dizziness: 18 people, 34.62%
- Diarrhea: 17 people, 32.69%
- Nasopharyngitis (inflammation of the nasopharynx): 17 people, 32.69%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 16 people, 30.77%
Common conditions people have *:
- Asthma: 14 people, 26.92%
- Muscle Aches (muscle pain): 13 people, 25.00%
- Psoriasis (immune-mediated disease that affects the skin): 7 people, 13.46%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.62%
- Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 3 people, 5.77%
- Birth Control: 3 people, 5.77%
- Diabetes: 3 people, 5.77%
- Hyperthyroidism (over activity of the thyroid gland): 2 people, 3.85%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 3.85%
- Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 2 people, 3.85%
* Approximation only. Some reports may have incomplete information.
Do you take Dexilant and have Heavy or prolong menstrual bleeding?Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
How severe was Heavy or prolong menstrual bleeding and when was it recovered:
Expand to all the drugs that have ingredients of dexlansoprazole:
Alternative drugs to, pros and cons of Dexilant:
- Dexilant (52,238 reports)
Common Dexilant side effects:
Browse all side effects of Dexilant:a b c d e f g h i j k l m n o p q r s t u v w x y z
Heavy or prolong menstrual bleeding treatments and more:
- Heavy or prolong menstrual bleeding (37,987 reports)
COVID vaccines that are related to Heavy or prolong menstrual bleeding:
- Heavy or prolong menstrual bleeding in Moderna COVID Vaccine
- Heavy or prolong menstrual bleeding in Pfizer BioNTech Covid Vaccine
- Heavy or prolong menstrual bleeding in Johnson and Johnson Covid Vaccine
Common drugs associated with Heavy or prolong menstrual bleeding:
All the drugs that are associated with Heavy or prolong menstrual bleeding:
- Heavy or prolong menstrual bleeding (1,678 drugs)
Common conditions associated with Heavy or prolong menstrual bleeding:
All the conditions that are associated with Heavy or prolong menstrual bleeding:
- Heavy or prolong menstrual bleeding (1,147 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dexlansoprazole (the active ingredients of Dexilant) and Dexilant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zyrtec and Apremilast drug interaction - a second ago
- Moxifloxacin and Brain Herniation - 2 seconds ago
- Aspirin and Subarachnoid Haemorrhage - 3 seconds ago
- Pemetrexed Disodium and Pantoprazole Sodium drug interaction - 3 seconds ago
- Indomethacin and Clostridium Difficile Colitis - 6 seconds ago
- Chestnut and Consciousness - Decreased - 7 seconds ago
- Xalkori and Haemorrhagic Stroke - 12 seconds ago
- Xyrem and Allergic Sinusitis - 16 seconds ago
- Furosemide and Joint Contracture - 16 seconds ago
- Oncovin and Nerve Injury - 17 seconds ago